Prostate Cancer
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
December 29, 2023
Role of adenosine deaminase in prostate cancer progression.
December 29, 2023
Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma.
December 29, 2023
A comparative study of spinal cord compression management in metastatic prostate cancer: Teaching versus non-teaching hospitals in the United States.
December 28, 2023
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
December 28, 2023
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
December 28, 2023
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
December 28, 2023
Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer.
December 27, 2023
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
December 27, 2023
The Impact of Nutrient Supply on Prostate Cancer Risk Worldwide.
December 27, 2023
Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy.
December 27, 2023
Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management.
December 26, 2023